InvestorsHub Logo
Followers 12
Posts 616
Boards Moderated 0
Alias Born 05/06/2016

Re: malamutus post# 3495

Wednesday, 06/15/2016 6:26:59 PM

Wednesday, June 15, 2016 6:26:59 PM

Post# of 232961
Not sure. He's on the monotherapy - so the most he should be experiencing is irritation around the injection site. With the combinational therapy there could be nausea, vomitting, etc. because patients are still taking the other anti-retrovirals that cause them. For the patients sake, I hope the monotherapy trials finishes first. It would also put more pressure on big pharma's to gobble CytoDyn up because we would effectively eliminate the need for all the other anti-retrovirals.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News